Regarding MTC site of action, the chemoreceptor trigger zone (CTZ) in the postrema region of the brain is where MTC mainly inhibits the dopamine D2 and serotonin 5-HT3 receptors, which are responsible for the antiemetic actions (Lee & Kuo, 2010). This evidence concerns the gene HTR3A and medullary thyroid gland carcinoma.